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A B S T R A C T
Objective: To evaluate the level of informed decision making in a randomized controlled trial comparing
colonoscopy and CT-colonography for colorectal cancer screening.
Methods: 8844 citizens aged 50–75 were randomly invited to colonoscopy (n = 5924) or CT-
colonography (n = 2920) screening. All invitees received an information leaﬂet. Screenees received a
questionnaire within 4 weeks before the planned examination, non-screenees 4 weeks after the
invitation. A decision was categorized as informed when characterized by sufﬁcient decision-relevant
knowledge and consistent with personal attitudes toward participation in screening.
Results: Knowledge and attitude items were completed by 1032/1276 colonoscopy screenees (81%), by
698/4648 colonoscopy non-screenees (15%), by 824/982 CT-colonography screenees (84%) and by 192/
1938 CT-colonography non-screenees (10%). 1027 colonoscopy screenees (>99%) and 815 CT-
colonography screenees (99%) had adequate knowledge; 915 (89%) and 742 (90%) had a positive
attitude. 675 non-screenees invited to colonoscopy (97%) and 182 invited to CT-colonography (95%) had
adequate knowledge; 344 (49%) and 94 (49%) expressed a negative attitude.
Conclusion: A large majority of screenees made an informed decision on participation. Almost half
of responding non-screenees, made an uninformed decision, suggesting additional barriers to
participation.
Practice implications: Efforts to understand the additional barriers will create opportunities to facilitate
informed participation to colorectal cancer screening.
 2013 Elsevier Ireland Ltd. 
Contents lists available at SciVerse ScienceDirect
Patient Education and Counseling
jo ur n al h o mep ag e: w ww .e lsev ier . co m / loc ate /p ated u co u
Open access under the Elsevier OA license.1. Introduction
Colorectal cancer is the second most prevalent cause of cancer
related deaths in the Western world [1–3]. Without screening the
life-time risk of colorectal cancer is 5–6% in Western countries [4].
The majority of colorectal cancers develop from adenomatous
polyps – benign precursors – after a long premalignant period.
Colorectal cancer screening can reduce both the incidence and
mortality of colorectal cancer by early detection and removal of* Corresponding author at: Department of Radiology, G1-228, Academic Medical
Centre, PO Box 22700, 1100 DE Amsterdam, The Netherlands. Tel.: +31 20 5662630;
fax: +31 20 5669119.
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Open access under the Elsevier OA license.adenomatous polyps and colorectal cancer [5–11]. A recent study
showed that the lifetime risk decreases to 4.4% when colorectal
cancer screening is offered to the general population [12].
Patient autonomy requires that people should be able to choose
at the individual level, free from coercion, whether they wish to
participate in screening or not [13]. To make a balanced decision
invitees require unbiased information on both the beneﬁts as well
as the harms of screening [14–17].
There are several deﬁnitions of informed decision, all including
the following two dimensions: the decision should be based on
decision-relevant knowledge and be consistent with the decision
maker’s attitude [18–21]. Screenees with adequate knowledge
about colorectal cancer and colorectal cancer screening and a
positive attitude toward participation make an informed decision
to participate. Analogously, non-screenees with adequate
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informed decision not to take part in screening. In case of
inadequate understanding or when making a decision not in line
with one’s attitudes, the action cannot be classiﬁed as an informed
decision.
Relevant knowledge can be evaluated by measuring the
invitees’ knowledge on characteristics of the condition for which
screening is offered, the screening test and implications of possible
results [22,23]. Previous studies showed that required knowledge
on the type of cancer (i.e. incidence) and the properties of a
screening test (i.e. accuracy and complication risk) is often limited
[24,25].
Colonoscopy and computed tomography-colonography (CT
colonography) are attractive options for colorectal cancer screen-
ing, as they are both full colonic examinations with a high accuracy
for advanced neoplasia [26,27]. As both are invasive techniques,
requiring preparation by laxatives or contrast agents, invitees may
be more inclined to reject participation to screening than when
invited for less invasive tests. To make an informed decision on
participation invitees should have enough decision-relevant
knowledge on colorectal cancer, as well as on the (dis)advantages
of colonoscopy or CT colonography. We evaluated the level of
informed decision making on participation in a randomized trial
comparing colonoscopy and CT colonography screening.
2. Methods
2.1. Patients and settings
Between June 2009 and July 2010, Dutch citizens aged 50–74
years were identiﬁed in the population registry in the regions of
Amsterdam and Rotterdam, and invited by postal mail to
participate in screening, randomly allocated 2:1 to colonoscopy
or CT colonography. The trial protocol has been described in detail
elsewhere [28]. Invitees were stratiﬁed for age, sex (individual
level data from the Dutch population registry) and socio-economicTable 1
Demographic characteristics of invitees returning their questionnaire.
Total invitees (n) Colonoscopy, n = 5924 
Screenees, n = 1276 Non-scre
Responding invitees 1167 (91%) 915 (20%
Median age in years (IQR) 60 (55–65) 60 (55–
Gender (% male) 50.8 44.3 
Married or living together (%) 86.4 82.8 
Children (% yes) 85.5 83.5 
Socio-economic status (mean, SD)a 3.2 (SD 1.4) 3.1 (SD 1
Education
Elementary (%) 3.8 6.1 
Secondary (%) 67.8 68.1 
Tertiary and postgraduate (%) 26.1 24.4 
Other (%) 2.3 1.4 
Employment status
Paid job(%) 50.1 47.6 
Not able to work (%) 4.9 5.8 
Retired (%) 33.8 34.3 
Other (%) 11.2 12.4 
Ethnical origine
Dutch 1094 (94%) 846 (92%
Other 57 (5%) 59 (6%)
Unknown 16 (1%) 10 (1%)
Prior colonoscopy experienceb
Yes 138 (12%) – 
No 859 (74%) 
Unknown 170 (15%) 
a Socio-economic status was scored as very low (1), low (2), medium (3), high (4) a
b This information was only collected in screenees.status (very low – very high). In the Netherlands, postal area code
can be linked to aggregated data on income level, education and
type of occupation of Dutch citizens (based on data from Statistics
Netherlands) [1]. At the time of the trial, the Netherlands did not
have a population-based colorectal cancer screening program.
Invitees were only allowed to undergo the allocated screening
modality. Ethical approval was obtained before study initiation
from the Dutch Health Council (2009/03WBO, The Hague, The
Netherlands). The trial was registered in the Dutch trial register:
NTR1829 (www.trialregister.nl).
2.2. Information leaﬂet and prior consultation
With the invitation, colonoscopy and CT colonography screen-
ing invitees received identically designed leaﬂets with information
on colorectal cancer and colorectal cancer screening. These leaﬂets
were derived from similar leaﬂets used in previous colorectal
cancer screening pilots. The information leaﬂet for colonoscopy
invitees contained speciﬁc information on beneﬁts and risks of
colonoscopy, while the information leaﬂet of CT colonography
invitees contained information on beneﬁts and risks of CT
colonography. Both leaﬂets contained information on follow-up
in case of a positive test result (e.g. follow-up colonoscopy in case
of a positive CT colonography result).
Invitees who responded to the invitation were scheduled for a
standardized consultation with a research fellow or research nurse
to inform them about the bowel preparation and the procedure
itself. In the CT colonography group all invitees were invited for a
prior consultation by telephone, while in the colonoscopy group
half of invitees were invited for a prior consultation at the
outpatient clinic [28]. Data on differences between the two
colonoscopy groups were recently published by Stoop et al. [29].
Responders were excluded from participation when they had
undergone a full colonic examination in the previous ﬁve years,
when they had a life expectancy of less than 5 years, or when they
had been previously scheduled for surveillance colonoscopyCT colonography, n = 2920
enees, n = 4648 Screenees, n = 982 Non-screenees, n = 1938
) 927 (94%) 257 (13%)
65) 59 (55–65) 61 (56–67)
51.1 41.2
85.0 80.8
87.2 89.1
.4) 3.1 (SD 1.4) 3.1 (SD 1.4)
5.0 8.1
60.5 57.9
31.9 31.6
2.6 2.4
50.4 40.5
3.4 6.1
35.0 42.1
11.2 11.3
) 874 (94%) 237 (92%)
 49 (5%) 20 (8%)
 4 (<1%) 0 (0%)
96 (10%) –
708 (76%)
123 (13%)
nd very high (5).
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polyps or inﬂammatory bowel disease. CT colonography respon-
ders were also excluded when they had been exposed to ionizing
radiation for research purposes within the previous 12 months or
when they had hyperthyroidism or iodine contrast allergy.
2.3. Questionnaire
All invitees received a questionnaire containing previously
validated measures of knowledge and an attitude measure based
on Marteau’s Multidimensional Measure of Informed Choice
[18,19,30–32]. Screenees received the questionnaire within 4
weeks before the screening procedure with the appointment
conﬁrmation, and were asked to return the questionnaire by
mail or to bring the questionnaire to the hospital. All invitees
who actively declined the invitation received the same
questionnaire, as well as those invitees that did not respond
within 4 weeks after the initial invitation (together with a
reminder letter). Those invitees who initially indicated that they
would like to participate, but changed their mind after the
consultation with a research fellow or nurse, also received this
questionnaire.
Knowledge among colonoscopy invitees was measured by
eight statements on colorectal cancer and colorectal cancer
screening and three statements on colonoscopy characteristics
and the consequences of a positive test result. For each
statement, respondents were invited to indicate whether it
was true or false. Knowledge among CT colonography inviteesTable 2
Knowledge statements on colorectal cancer and on colorectal cancer screening, screen
Information in leaﬂet Statements (correct answer
in parentheses)
Colonosco
Screenees
n = 1165
Colorectal cancer is the most
prevalent cancer in men after
prostate cancer and lung cancer.
In women, colorectal cancer is
the most prevalent cancer after
breast cancer.
1. Colorectal cancer is one of the
most prevalent cancers. (TRUE)
79.1 
Population based colorectal cancer
screening can detect colorectal
cancers in an early stage, when a
patient is still asymptomatic.
2. Population based colorectal
cancer screening can detect
colorectal cancers in
participants before they
become symptomatic. (TRUE)
96.6 
Participation to this population-
based colorectal cancer screening
is voluntary.
3. Participation to the
population-based colorectal
cancer screening is obliged for
all subjects aged 50–75 years.
(FALSE)
82.3 
If colorectal cancer is detected
early, it can be treated well. The
chance on curing the disease by
treatment becomes larger.
4. If colorectal cancer is
detected in an early stage, the
chance of being deathly
becomes smaller. (TRUE)
98.2 
Colorectal polyps are usually not
symptomatic. colorectal cancer
in an early stage is usually
asymptomatic.
5. If an invitee feels healthy, it is
not useful to participate.
(FALSE)
96.3 
Colorectal cancer in an early stage
is usually asymptomatic.
6. It is possible to have
colorectal cancer, even if you
are not symptomatic. (TRUE)
97.6 
Precursors of colorectal cancer can
be removed before they become
malignant.
7. Early removal of polyps
reduces the future chance of
being diagnosed with
colorectal cancer in the
future becomes smaller. (TRUE)
96.0 
Not stated. 8. If colorectal cancer is
detected on colonoscopy, the
most common treatment is
surgical removal. (TRUE)
82.2 was measured by the same eight knowledge statements on
colorectal cancer and colorectal cancer screening and six
statements on the characteristics of CT colonography and
follow-up colonoscopy in case of a positive CT-colonography
(Tables 2 and 3). Knowledge was classiﬁed as adequate if more
than half of the statements had been correctly identiﬁed as true
or false.
Attitude toward screening among colonoscopy and CT colono-
graphy invitees was measured by offering respondents four
statements, to which they could respond each on a seven-point
Likert-scales. The statements were: ‘participation in the popula-
tion-based colorectal cancer screening trial is a bad idea–not a bad
idea’ for me, ‘. . . useful–not useful’, ‘. . . harmful–beneﬁcial’ and ‘. . .
a good idea–not a good idea’. An attitude score was calculated by
summing up the responses to the four items, resulting in a score
ranging from 4 to 28. Attitude scores of 17 points or higher were
classiﬁed as reﬂecting a positive attitude [18]. The attitude scale
was based on Marteau’s attitude scale which has been translated
into Dutch using procedures in line with international guidelines,
including independent forward and backward translation [33]. The
translated attitude scale was validated in other screening studies
[34–36].
The questionnaire also contained questions on marital status,
children, education and employment status. Screenees were asked
to complete the questionnaire prior to the screening procedure and
to return it by mail or to bring it to the screening procedure.
Questionnaires, ﬁlled out after the screening procedure were
excluded from the analysis.ees versus non-screenees.
py % correct CT colonography % correct
, Non-screenees,
n = 909
p-Value Screenees,
n = 923
Non-screenees,
n = 256
p-Value
74.8 0.02 76.3 71.5 0.12
88.7 0.001 95.6 91.0 0.01
87.2 0.002 85.7 87.1 0.57
94.2 <0.001 97.6 94.1 0.01
83.8 <0.001 97.2 83.2 <0.001
90.8 <0.001 97.2 91.4 <0.001
89.4 <0.001 93.5 85.9 <0.001
72.9 <0.001 73.1 64.5 0.01
Table 3
Knowledge statements on characteristics of colonoscopy and CT colonography, screenees versus non-screenees.
Information in leaﬂet Knowledge among colonoscopy invitees on
characteristics of colonoscopy (correct
answer in parentheses)
Screenees,
n = 1156
Non-screenees,
n = 909
p-Value
In 1 on 1000–10.000 examinations
complications occur, like a
bleeding. In addition, it is
possible that the bowel wall is
perforated during the
examination.
9. A colonoscopy can lead accidentally to a bleeding
and/or perforation of the bowel. (TRUE)
90.6 77.8 <0.001
There is a small chance that
colorectal cancer will be missed
during colonoscopy (<1%).
10. Colonoscopy gives almost 100% conﬁdence on
the presence of polyps and/or colorectal cancer.
(TRUE)
86.4 72.7 <0.001
In most cases, polyps will be
removed during the colonoscopy.
11. If polyps are detected during colonoscopy, they
can be directly removed in most cases. (TRUE)
97.7 80.4 <0.001
Information in leaﬂet Knowledge among CTC invitees on characteristics
of CT colonography (correct answer in parentheses)
Screenees,
n = 923
Non-screenees,
n = 256
p-Value
The colon can be visualized using a CT-
scanner. This makes it possible to
examine the colon from outside,
without the need for an endoscope.
9. During CT colonography the large bowel is
visualized using an endoscope. (FALSE)
83.7 51.2 <0.001
To prepare the large bowel, CO2 will be
insufﬂated.
10. During CT colonography CO2 will be
insufﬂated in the bowel. (TRUE)
94.7 73.4 <0.001
If 100 subjects underwent CT
colonography, it would detect polyps
or colorectal cancer in about 6
subjects.
11. In 100 participants, CT colonography will
detect polyps or colorectal cancer in
approximately 14 subjects. (FALSE)
64.9 57.8 0.04
If suspicious colorectal lesions are
detected on CT colonography, you
will be referred for a colonoscopy.
12. If polyps are detected on CT colonography,
they can be removed directly. (FALSE)
89.1 62.1 <0.001
If suspicious colorectal lesions are
detected on CT colonography, you
will be referred for a colonoscopy.
13. If polyps and/or colorectal cancer are
detected on CT colonography, a follow-up
examination (colonoscopy) is needed.
(TRUE)
96.5 90.2 <0.001
During this follow-up colonoscopy,
polyps and colorectal cancer can be
detected and if possible they can also
be removed directly.
14. If this follow-up examination (colonoscopy)
detects polyps, they can be removed
directly in most cases. (TRUE)
73.3 67.2 0.05
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Invitees with adequate decision-relevant knowledge and a
positive attitude toward screening who actually participated
were classiﬁed as having made an informed decision. So
were invitees with adequate knowledge and a negative
attitude who had declined the invitation. All other combinations
– inadequate knowledge or actions inconsistent with
attitudes toward screening – were considered to be uninformed
decisions. In the result section we focused on the largest
differences in knowledge between screenees and non-
screenees.
2.5. Statistical analysis
We calculated the proportion of people with adequate
knowledge, the proportion of people with a positive
attitude, and the proportion that made an informed decision
for the colonoscopy group and for the CT colonography
group. These proportions were calculated for the group of
screenees and for the group of non-screenees who returned
the questionnaire. Differences in knowledge scores between
screenees and non-screenees were assessed using chi-square
statistics.3. Results
Between June 2009 and July 2010, 8844 citizens aged 50–74
were randomly allocated to colonoscopy (n = 5924) or to CT
colonography (n = 2920). Of these invitees, 1194 (94%) colonosco-
py screenees and 945 (96%) CT colonography screenees returned
the questionnaire, and 915 (20%) of colonoscopy non-screenees
and 257 (13%) of CT colonography non-screenees (Fig. 1). Those
invitees who initially indicated that they would like to participate,
but changed their mind after the consultation with a research
fellow or nurse, also received this questionnaire (n = 91 in
colonoscopy and n = 105 in CT colonography). Twenty-seven
questionnaires of colonoscopy screenees and 18 questionnaires
of CT colonography screenees had to be excluded, as they were
completed after the screening procedure.
Both knowledge and attitude items were completed by 1032
of 1276 colonoscopy screenees (81%), by 698 of 4648 colonos-
copy non-screenees (15%), by 824 of 982 CT colonography
screenees (84%) and by 192 of 1938 CT colonography non-
screenees (10%). There was no difference between
responding screenees and responding non-screenees in age or
socio-economic status. In both colonoscopy and CT colonogra-
phy non-screenees, women more often returned the question-
naire than men (Table 1).
8,84 4 invite es
1,194 (94%)
return ed  quesonna ire
Data complete:
909 knowledge 
700 atude
Data complete:
1,165 know ledge
1,033 atude
Data complete:
923 knowledge 
828 attude
27 excluded ;
complet ed  aer 
procedure
18 excluded ;
complet ed  aer 
procedure
5,924 colonos copy  in vite es 2,920 CT co lonograph y invite es
1,938 (66%)
non-scr een ees
982 (34%)
screen ees 
4,648 (78%)
non-screen ees
1,276 (22%) 
screen ees 
945 (96%)
return ed  quesonna ire
Data complete:
256 kno wledge 
193 atude
915 (20%)
return ed  quesonna ire
0 exc luded
257 (13%)
return ed  quesonna ire
0 exc luded
Fig. 1. Overview of response.
Negative attitude
Positive attitude
CS CTC
50%
0%
N=1,033 N=828N=700 N=193
100%
P NP P NP
Note: Table 4a  and 4b 
provide info rmation on 
the number of 
(non)screenees  mak ing 
an infor med de cision.
10.8 vs . 52 .1 9.1 vs . 51.8 
89.2 vs . 47.9 90.9 vs . 48.2 
Fig. 2. Screenees (P) vs. non-screenees (NP).
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Overall, 99% of colonoscopy screenees and 98% of CT
colonography screenees could be classiﬁed as having adequate
knowledge about colorectal cancer (screening) and the allocated
screening modality, compared to 95% of colonoscopy non-screen-
ees and 92% of CT colonography non-screenees.
3.2. Knowledge statements on colorectal cancer and colorectal cancer
screening
Details are displayed in Table 2.
Screenees: Five of the eight knowledge statements on colorectal
cancer and screening were answered correct by a large majority of
colonoscopy and CT colonography screenees: statement 2 (97%
versus 96%), 4 (98% versus 98%), 5 (96% versus 97%), 6 (98% versus
96%), and 7 (96% versus 94%).
Non-screenees: Five out of eight knowledge statements on
colorectal cancer and screening were answered correct by 86% of
colonoscopy and CT colonography non-screenees: statement 2
(89% versus 91%), 3 (both 87%), 4 (both 94%), 6 (both 91%), and 7
(89% versus 86%).
Screenees versus non-screenees: The largest difference be-
tween screenees and non-screenees in percentage of correct
responses was found for the following statement: ‘‘if an invitee
feels healthy, it is not useful to participate’’: 96% of colonoscopy
screenees indicated this was false versus 84% of non-screenees
(p < 0.001). In the CT colonography group 97% of screenees
indicated this was false versus 83% of non-screenees (p < 0.001).
In colonoscopy invitees, the second largest difference was found
for the following statement: ‘‘population based screening can
detect colorectal cancer before it becomes symptomatic’’ (97% of
screenees versus 89% of non-screenees  indicated this was true;
p < 0.001). In CT colonography, the second largest difference was
found for: ‘‘early removal of polyps reduces the future chance
of being diagnosed with colorectal cancer in the future’’ (94% of
screenees versus 86% of non-screenees  indicated this was true;
p < 0.001).3.3. Knowledge statements on the screening modality
Results on the knowledge statements about the screening
modality are displayed in Table 3.
Table 4b
Informed decisions among non-screenees.
Colonoscopy, n = 698 CT colonography, n = 192
Sufﬁcient knowledge, positive attitude 47.4% (331) 44.8% (86)
Sufﬁcient knowledge, negative attitude 49.3% (344)a 49.0% (94)a
Insufﬁcient knowledge, positive attitude 0.6% (4) 3.6% (7)
Insufﬁcient knowledge, negative attitude 2.7% (19) 2.6% (5)
a Non-screenees in these categories made an informed decision.
Table 4a
Informed decisions among screenees.
Colonoscopy, n = 1032 CT colonography, n = 824
Sufﬁcient knowledge, positive attitude 88.7% (915)a 90.0% (742)a
Sufﬁcient knowledge, negative attitude 10.9% (112) 8.7% (72)
Insufﬁcient knowledge, positive attitude 0.5% (5) 0.8% (7)
Insufﬁcient knowledge, negative attitude 0% (0) 0.4% (3)
a Screenees in these categories made an informed decision.
M.C. de Haan et al. / Patient Education and Counseling 91 (2013) 318–325 323Screenees: Two out of three statements on colonoscopy were
answered correctly by a large majority of colonoscopy screenees:
‘‘colonoscopy can lead to bleeding and/or perforation’’ (91%) and
‘‘if polyps are detected during colonoscopy, they can be directly
removed in most cases’’ (98%). Two out of six statements on CT
colonography were answered correctly by a large majority of CT
colonography screenees: ‘‘during CT colonography CO2 will be
insufﬂated in the bowel’’ (95%) and ‘‘if polyps and/or colorectal
cancer are detected on CT colonography, a follow-up examination
(colonoscopy) is needed’’ (97%).
Non-screenees: The percentage of correct responses of colonos-
copy non-screenees on three statements on colonoscopy, ranged
from 73% to 80%. The following statement was answered most
often correctly: ‘‘if polyps are detected during colonoscopy, they
can be directly removed in most cases’’. The percentage of correct
responses for the statements on CT colonography and follow-up
colonoscopy among CT colonography non-screenees ranged
between 51% and 90%. Low scores were observed for the following
statements: ‘‘during CT colonography the large bowel is visualized
using an endoscope’’ (51%) and ‘‘in 100 participants, CT colono-
graphy will detect polyps or colorectal cancer in approximately 14
subjects’’ (58%).
Screenees versus non-screenees: The largest difference in correct
answers between colonoscopy screenees and non-screenees was
found for the following statement: ‘‘if polyps are detected during
colonoscopy, they can be directly removed in most cases’’ (98%
versus 80%; p < 0.001). All statements presented to CT colono-
graphy invitees were more often answered correctly by screenees.
The largest differences in correct responses were observed for the
following statements: ‘‘during CT colonography the large bowel is
visualized using an endoscope’’ (84% of screenees versus 51% of
non-screenees; p < 0.001), ‘‘if polyps are detected on CT colono-
graphy, they can be removed directly’’ (89% versus 62%; p < 0.001)
and ‘‘during CT colonography CO2 will be insufﬂated in the bowel’’
(95% versus 73%; p < 0.001).
3.4. Attitude
The results on the attitude of screenees and non-screenees are
shown in Fig. 2. Cronbach’s alphas of the attitude scales of
colonoscopy and CT colonography were 0.83 and 0.82, respective-
ly, indicating high internal consistency. Overall, 89% of colonosco-
py and 91% of CT colonography screenees had an attitude score of
17 or more and were classiﬁed as having a positive attitude toward
screening. In contrast, 48% of responding colonoscopy and CT
colonography non-screenees had a positive attitude toward
screening.3.5. Informed decision making
Tables 4a and 4b show the results on informed decision making
for screenees and non-screenees, respectively.
Screenees: 1027 of 1032 (>99%) colonoscopy screenees who
completed both knowledge and attitude items had adequate
knowledge; 915 (89%) colonoscopy screenees also had a positive
attitude; 815 of 824 (99%) CT colonography screenees who
completed both items had adequate knowledge and 742 (90%)
also had a positive attitude.
Non-screenees: 675 of 698 (97%) colonoscopy non-screenees
had adequate knowledge, 344 (49%) also had a negative attitude. Of
the 192 responding CT colonography non-screenees, 180 (94%) had
adequate knowledge and 94 (49%) also had a negative attitude.
3.6. Uninformed decision making
Non-screenees often had adequate knowledge and a positive
attitude toward screening: 47% of responding colonoscopy non-
screenees (331/698) and 45% of responding CT colonography non-
screenees (86/192).
4. Discussion and conclusion
4.1. Discussion
Our study shows that a large majority of colonoscopy and CT
colonography screenees make informed decisions about taking
part in a population-based colorectal cancer screening program,
compared to about half of responding non-screenees. Both in the
colonoscopy and in the CT colonography almost half of the
responding non-screenees had adequate knowledge and a positive
attitude, suggesting the existence of additional barriers to
participation.
Our study has several strengths. Data were collected in a large
pilot colorectal cancer screening program, designed as a random-
ized trial. All invitations were sent in the same time period,
minimizing external inﬂuences through general public awareness.
The information leaﬂets of both examinations were identically
designed where appropriate and all screenees received a stan-
dardized consultation to inform them about the entire screening
procedure.
At the time of our study, the Netherlands did not have a
population-based colorectal cancer screening program. The deci-
sion to participate in a randomized trial, such as this one, differs
from the decision to participate in a population-based screening
program. It is very well possible that the willingness to participate
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part in a more widely announced national screening program. As
such, the proportions observed in our study do not unconditionally
apply to population-based screening programs in general. We
should also mention that the deﬁnition of informed decision
making as deﬁned by Marteau et al. is not perfect. In decision-
making about screening there may be predictable barriers to
participation, like expected burden and immobility of an invitee,
and unpredictable barriers, such as an acute illness, which might
result in differences between intended and actual behavior [37].
We deﬁned adequate knowledge as correct responses to more
than half of the knowledge items, an arbitrary cut-off. There are
several other ways to deﬁne adequate knowledge like using the
mean score as a distribution-based cut-off point [18] or scores
above the guess-corrected midpoint. We used a norm-based cut-
off, as we believe that sufﬁcient knowledge of an individual should
not be based on the relative knowledge of other subjects, but on a
minimum of desired knowledge.
Since the introduction of the deﬁnition of informed decision as
deﬁned by Marteau et al, several studies have evaluated the level of
informed decision making in cancer screening [38,34]. Compared
to previous studies, we found a relatively high number of screenees
and non-screenees with adequate knowledge, while the percent-
age of screenees with a positive attitude in our study was only
slightly lower. The ﬁrst study on informed decision making in
screening was performed within a RCT of CT screening for lung
cancer in high-risk individuals [37]. That study was most
comparable to our study, as the authors also deﬁned adequate
knowledge and positive attitude as scores above the midpoint of
the complete scales. Overall, 73% of screenees and 54% of non-
screenees were found to have adequate knowledge, while 99% of
screenees and 64% of non-screenees had a positive attitude toward
screening. Another study [34] was conducted in a population-
based cervical cancer screening program using a Pap smear.
Invitees received a questionnaire, together with their invitation
and standard information leaﬂet. Sixty-four percent of responding
screenees had sufﬁcient knowledge and 99% was found to have a
positive attitude toward screening. That study was less compara-
ble to our study, as at least 6 out of 7 knowledge items had to be
answered correctly. As far as we know, no other studies have been
published on informed decision-making in colorectal cancer
screening using colonoscopy or CT colonography.
Compared to these previous studies, a relative high number of
screenees made an informed decision in our program. This may be
explained by variability in methods, such as differences in the type
or amount of information given in the information leaﬂet and in
deﬁning adequate knowledge, or by the fact that all screenees in
this trial had a prior consultation before they underwent the
examination. A second explanation for the different results could
be the variety in diseases under evaluation, including the
subsequent possibility of differences in prior knowledge among
invitees.
Both in colonoscopy and CT colonography, some knowledge
statements were more often answered incorrectly by non-
screenees than by screenees, such as ‘If an invitee feels healthy,
it is not useful to participate’. These results indicate that screenees
are more often aware than non-screenees that someone can have
cancer without being symptomatic. This contrast is consistent with
ﬁndings of a previous study [39]. Our results also show that
invitees were not always familiar with the difference between
colonoscopy and CT colonography, as 49% of CT colonography non-
screenees thought that the large bowel was visualized with an
endoscope during CT colonography. Since adequate knowledge
regarding these statements is important for understanding the
primary aim of a screening program and a necessary condition for
making an informed decision on participation, we should investadditional efforts in developing future leaﬂets and further
improving the information process.
Unfortunately, only a minority of non-screenees returned their
questionnaire. A low response rate among non-screenees is a
common problem in studies [38]. It can be argued that these non-
screenees represent a selected group, with an overrepresentation
of knowledgeable people with a positive attitude. We found no
difference in median age and mean socio-economic status between
responding screenees and non-screenees in either arm, and only a
small difference in ratio of responding men and women.
Nevertheless, we do not suggest that the results can uncondition-
ally be generalized to all non-screenees. Despite the likelihood of
selective response, the existence of a relatively large group of
people with adequate decision-relevant knowledge and a positive
attitude toward screening participation, who nonetheless decided
not to participate, suggests that there are additional barriers
toward participation. Exploration of these barriers may offer new
opportunities to eradicate them and to facilitate informed
participation. Recently, results on reasons for participation and
non-participation were published [40]. For colonoscopy invitees,
the main decisive reason not to participate was the expected
unpleasantness of the examination in colonoscopy while the
majority of responding CT colonography non-screenees declined
their invitation because they had no time/they found it too much
effort or because of lack of symptoms.
4.2. Conclusion
Our results show that a large majority of screenees in a
randomized colorectal cancer screening trial comparing colonos-
copy and CT colonography made an informed decision on
participation. This means that it is very well possible to organize
population-based colorectal cancer screening programs in such a
way that the principle of informed decision-making can be
adhered to. In contrast, only half of responding non-screenees
made an informed decision on non-participation, suggesting that
there are additional barriers toward participation.
4.3. Practice implications
The ﬁnding that non-participation was based on uninformed
decision-making in half of the responding non-screenees suggests
additional barriers toward participation. Future efforts should offer
more insight in these additional participation barriers, and help us
in the design of future information campaigns and in creating
circumstances to further facilitate informed participation.
‘‘I conﬁrm all patient/personal identiﬁers have been removed or
disguised so the patient/person(s) described are not identiﬁable
and cannot be identiﬁed through the details of the story.’’
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